Dr. Erik Stephen Cabral, MD

Dr. Cabral practices at Center for Dermatology Cosmetic & Laser Surgery-Fremont Office in Fremont, California.

Dr. Cabral's NPI, 1023252350, was assigned on April 30, 2009. Dr. Cabral graduated from Stanford University School Of Medicine in 2009. Dr. Cabral holds California license A114735.

Dr. Cabral's primary practice is Center for Dermatology Cosmetic & Laser Surgery-Fremont Office, at 2557 Mowry Ave, Fremont, CA 94538 in Alameda County. The practice phone is (510) 797-4111.

Dr. Cabral's primary practice is Center for Dermatology Cosmetic & Laser Surgery-Fremont Office in Fremont, California. The medical group on file is Schweiger Dermatology Group, San Pedro. Dmand AI also links Dr. Cabral to 10 more medical groups, 4 group practices and clinics and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cabral practices, 5 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Cabral's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Cabral is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Cabral's licenses on file in 2 states: California and Arizona.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, itchy rashes, rash and scalp rash among the conditions Dr. Cabral treats.

CMS data shows 18,342 Medicare services from Dr. Cabral across 29 procedure codes in 2024, for 402 Medicare patients. Medicare paid $423,345 for them. Every service was in an office.

CMS counts 402 Medicare patients who saw Dr. Cabral in 2024. The largest group is 65 to 74, with 162 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cabral's median patient age at 69, with 47% women.

In 2024, Dr. Cabral wrote 654 Medicare Part D claims for 262 patients. 97% of them were for generic drugs. CMS names the drug for 583 of them, across 13 drugs with 11 or more claims each, at $15,631 in total drug cost. In 2023, CMS named 459 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Cabral for performance year 2024, reported as part of a group. Dr. Cabral accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 50 procedures of melanoma (skin cancer) excision by Dr. Cabral, more than 86% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Cabral in 2006. The most frequent topics are Skin Neoplasms, Borrelia burgdorferi and Brain. Dr. Cabral has published most often in Dermatol Surg. Dr. Cabral's most frequent co-authors are Richard Gary Bennett, MD, Adam Michael Rotunda, MD and Elisabeth K. Shim, MD.

CMS Open Payments shows 70 general payments to Dr. Cabral from 19 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 98% of the total. LEO Pharma Inc. paid the most, $400.

Dmand AI lists 1 award for Dr. Cabral, most recently Fellow in 2003.

Dr. Cabral graduated from Stanford University School Of Medicine in 2009. Dr. Cabral is a member of AAD and American Society for Dermatologic Surgery.

Dr. Cabral is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.